CD274 and neoplasm: Moreover, in addition to PD-L1-expressing tumor cells, PD-L1-expressing tumor-infiltrating myeloid cells appeared to provide a compensatory source of the inhibitory ligand to downregulate the anti-tumor immune responses mediated by T cells in mice [34].